{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:23:35Z","timestamp":1792023815039,"version":"4.4.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,19]],"date-time":"2027-08-19T00:00:00Z","timestamp":1818633600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA017729"],"award-info":[{"award-number":["R01 AA017729"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AA032418"],"award-info":[{"award-number":["1R01AA032418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R 01 AA011576"],"award-info":[{"award-number":["R 01 AA011576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_189072"],"award-info":[{"award-number":["320030_189072"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030 _159984"],"award-info":[{"award-number":["320030 _159984"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_10003152"],"award-info":[{"award-number":["320030_10003152"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jhep.2026.04.025","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:44:05Z","timestamp":1777495445000},"page":"612-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uncovering immune dysfunction in ACLF: Cellular mechanisms, molecular pathways, and therapeutic frontiers"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-7069","authenticated-orcid":false,"given":"Marti","family":"Ortega-Ribera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-289X","authenticated-orcid":false,"given":"Robert","family":"Brenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-0503","authenticated-orcid":false,"given":"Christine","family":"Bernsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-2527","authenticated-orcid":false,"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.04.025_bib1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/gutjnl-2023-330584","article-title":"Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers","volume":"73","author":"Trebicka","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib2","article-title":"Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment","volume":"3","author":"Zaccherini","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib3","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(15)00309-8","article-title":"Acute-on-chronic liver failure","volume":"386","author":"Bernal","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.jhep.2026.04.025_bib4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-Chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cld.2014.05.004","article-title":"Acute-on-Chronic liver failure","volume":"18","author":"Asrani","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-322161","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","volume":"71","author":"Mezzano","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","article-title":"Dysfunctional immune response in acute-on-chronic liver failure: it takes two to tango","volume":"10","author":"Martin-Mateos","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib10","article-title":"Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure","volume":"5","author":"Cl\u00e0ria","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib11","article-title":"Systemic inflammation and acute-on-chronic liver failure: too much, not enough","volume":"2018","author":"Laleman","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MEG.0000000000001026","article-title":"Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure","volume":"30","author":"Zhang","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/intimm\/dxac030","article-title":"Liver cirrhosis and immune dysfunction","volume":"34","author":"Hasa","year":"2022","journal-title":"Int Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib16","first-page":"1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"The ACCP\/SCCM Consensus Conf Committee Am Coll Chest Physicians\/Society Crit Care Med Chest"},{"key":"10.1016\/j.jhep.2026.04.025_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02013","article-title":"Abnormal innate immunity in acute-on-chronic liver failure: immunotargets for therapeutics","volume":"11","author":"Khanam","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/17474124.2022.2097070","article-title":"Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?","volume":"16","author":"Abbas","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","author":"Moreau","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib20","article-title":"Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation","volume":"46","author":"Bernal","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jhep.2026.04.025_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0043-1776773","article-title":"Novel therapeutic approaches in treatment of acute-on-chronic liver failure","volume":"43","author":"Saeidinejad","year":"2023","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15647","article-title":"Extracorporeal liver support and liver transplantation for acute-on-chronic liver failure","volume":"45","author":"Ballester","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/JLB.4MIR0220-574RR","article-title":"Neutrophils at the crossroads of innate and adaptive immunity","volume":"108","author":"Rosales","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2026.04.025_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619039","article-title":"Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF","volume":"11","author":"Weiss","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib25","article-title":"A novel multi-organ male model of alcohol-induced acute-on-chronic liver failure reveals NET-mediated hepatocellular death, which is prevented by RIPK3 inhibition","volume":"19","author":"Ortega-Ribera","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98086-6","article-title":"Inflammatory signature in acute-on-chronic liver failure includes increased expression of granulocyte genes ELANE, MPO and CD177","volume":"11","author":"Saha","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib27","article-title":"Circulating neutrophil dysfunction in HBV-related acute-on-chronic liver failure","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jgh3.12344","article-title":"Neutrophil dysfunction predicts 90-day survival in patients with acute on chronic liver failure: a longitudinal case\u2013control study","volume":"4","author":"Makkar","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.jhep.2026.04.025_bib29","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3390\/biomedicines12092048","article-title":"Neutrophil extracellular trap scores predict 90-day mortality in hepatitis B-related acute-on-chronic liver failure","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhep.2026.04.025_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200644","article-title":"Monocyte human leukocyte antigen \u2013 antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure","volume":"13","author":"Satsangi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.04.025_bib31","article-title":"Patient plasma-induced neutrophil dysfunction is associated with infection risk and mortality in patients with acute decompensation of cirrhosis","author":"Sriphoosanaphan","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.04.025_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fimmu.2019.00346","article-title":"Neutrophil heterogeneity as therapeutic opportunity in immune-mediated disease","volume":"10","author":"Grieshaber-Bouyer","year":"2019","journal-title":"Front Immunol"},{"issue":"25","key":"10.1016\/j.jhep.2026.04.025_bib33","first-page":"2630","article-title":"Maladaptive emergency granulopoiesis predicts poor outcomes in patients hospitalized with decompensated cirrhosis","volume":"S0168\u20138278","author":"Aguilar","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nri3660","article-title":"Emergency granulopoiesis","volume":"14","author":"Manz","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00369-17","article-title":"Impairment of hematopoietic precursor cell activation during the granulopoietic response to bacteremia in mice with chronic-plus-binge alcohol administration","volume":"85","author":"Shi","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.jhep.2026.04.025_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep38714","article-title":"Low expression of CXCR1\/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib37","article-title":"Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure","volume":"3","author":"Kerbert","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2021.08.009","article-title":"Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure","volume":"76","author":"Zhang","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"Innate immune cells in cirrhosis","volume":"73","author":"Bernsmeier","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep32341","article-title":"Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis","volume":"6","author":"Sol\u00e9","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib41","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.31738","article-title":"Dysregulation of the lysophosphatidylcholine\/autotaxin\/lysophosphatidic acid Axis in acute-on-chronic liver failure is associated with mortality and systemic inflammation by lysophosphatidic acid-dependent monocyte activation","volume":"74","author":"Trovato","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.025_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","article-title":"Patients with acute on chronic liver failure display \u2018sepsis-like\u2019 immune paralysis","volume":"42","author":"Wasmuth","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/gutjnl-2017-314184","article-title":"CD14+ CD15\u2212 HLA-DR\u2212 myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure","volume":"67","author":"Bernsmeier","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib45","series-title":"Targeting the expansion of myeloid-derived suppressor cells in liver cirrhosis","author":"Flint","year":"2024"},{"key":"10.1016\/j.jhep.2026.04.025_bib46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140196","article-title":"PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury","volume":"131","author":"Triantafyllou","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.04.025_bib48","first-page":"S208","article-title":"PD-L1 expression of monocytes relates to severity, infection and mortality in acute-on-chronic liver failure","volume":"75","author":"Triantafyllou","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib49","doi-asserted-by":"crossref","unstructured":"Brenig R, Pop OT, Triantafyllou E, et al. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis. Life Sci Alliance; 3. Epub ahead of print 1 January 2020. DOI: 10.26508\/lsa.201900465.","DOI":"10.26508\/lsa.201900465"},{"key":"10.1016\/j.jhep.2026.04.025_bib50","doi-asserted-by":"crossref","first-page":"G237","DOI":"10.1152\/ajpgi.00371.2015","article-title":"Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis","volume":"311","author":"Wang","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2026.04.025_bib51","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.4049\/jimmunol.1001952","article-title":"Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells","volume":"186","author":"Pena","year":"2011","journal-title":"The J Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-018-0253-5","article-title":"Induction of innate immune memory via microRNA targeting of chromatin remodelling factors","volume":"559","author":"Seeley","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.025_bib53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2015.02.020","article-title":"Decreased Tim-3 expression is associated with functional abnormalities of monocytes in decompensated cirrhosis without overt bacterial infection","volume":"63","author":"Shi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib54","article-title":"Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression","author":"Liang","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhep.2024.12.031","article-title":"Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emerges","volume":"83","author":"Geng","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.856587","article-title":"Bioenergetic failure drives functional exhaustion of monocytes in acute-on-chronic liver failure","volume":"13","author":"Maheshwari","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/gutjnl-2020-323395","article-title":"PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF","volume":"71","author":"Li","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib58","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1136\/gutjnl-2018-316888","article-title":"Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity","volume":"68","author":"Korf","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12967-023-04294-1","article-title":"Intrahepatic macrophage reprogramming associated with lipid metabolism in hepatitis B virus-related acute-on-chronic liver failure","volume":"21","author":"Peng","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41598-017-00221-9","article-title":"NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jgh.16870","article-title":"Characterization of NK cells using single-cell RNA sequencing in patients with acute-on-chronic liver failure","volume":"40","author":"Zhao","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib62","unstructured":"Hj L, N Y, X M, et al. Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure. - Abstract - Europe PMC."},{"key":"10.1016\/j.jhep.2026.04.025_bib63","article-title":"Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure","volume":"5","author":"Liang","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell\u2013mediated deletion","volume":"210","author":"Peppa","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fimmu.2017.00301","article-title":"Immunoregulatory role of NK cells in tissue inflammation and regeneration","volume":"8","author":"Tosello-Trampont","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15644","article-title":"Mechanisms of immunity in acutely decompensated cirrhosis and acute-on-chronic liver failure","volume":"45","author":"Engelmann","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib67","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gutjnl-2021-324071","article-title":"Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis","volume":"71","author":"Khamri","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib68","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-024-46047-8","article-title":"BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion","volume":"15","author":"Yu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.025_bib69","doi-asserted-by":"crossref","unstructured":"Rueschenbaum S, Ciesek S, Queck A, et al. Dysregulated adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure. Front Immunol; 11. Epub ahead of print 26 January 2021. DOI: 10.3389\/fimmu.2020.534731.","DOI":"10.3389\/fimmu.2020.534731"},{"key":"10.1016\/j.jhep.2026.04.025_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1656692","article-title":"Extracellular vesicles of patients with acute-on-chronic liver failure induce mitochondrial dysfunction in T cells","volume":"16","author":"Langer","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1390458","article-title":"Deregulation of regulatory T cells in acute-on-chronic liver failure: a rat model","volume":"2017","author":"Ni","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jhep.2026.04.025_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9140602","article-title":"Treg\/Th17 cell balance in patients with hepatitis B virus-related acute-on-chronic liver failure at different disease stages","volume":"2021","author":"Tan","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib73","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/liv.14015","article-title":"Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure","volume":"39","author":"Khanam","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib74","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41575-025-01118-z","article-title":"Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment","volume":"22","author":"Brown Romero","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib75","article-title":"Macrophage-derived IL-15 imprints peritoneal TRM-like CD8 T cells in cirrhosis and spontaneous bacterial peritonitis","volume":"7","author":"Ibidapo-Obe","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib76","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10875-012-9678-z","article-title":"Enhanced peripheral \u03b3\u03b4T cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression","volume":"32","author":"Chen","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1041176","article-title":"Characterization of intrahepatic B cells in acute-on-chronic liver failure","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.70012","article-title":"Single-cell transcriptome identifies a proinflammatory B-cell subset in hepatitis B virus associated acute-on-chronic liver failure","volume":"32","author":"Wang","year":"2025","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2026.04.025_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70350","article-title":"Secretory IgA is a key marker among gut barrier dysfunction-related immunoglobulins predicting outcomes in ACLF","volume":"45","author":"Balogh","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867261","article-title":"Lipids in liver failure syndromes: a focus on eicosanoids, specialized pro-resolving lipid mediators and lysophospholipids","volume":"13","author":"Artru","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib81","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jhep.2020.03.046","article-title":"Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis","volume":"73","author":"L\u00f3pez-Vicario","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib82","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jhep.2021.06.043","article-title":"Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis","volume":"75","author":"Cl\u00e0ria","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib83","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2020.07.019","article-title":"Serum levels of metabolites produced by intestinal microbes and lipid moieties independently associated with acute-on-chronic liver failure and death in patients with cirrhosis","volume":"159","author":"Bajaj","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib84","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep4.1561","article-title":"Serum sphingosine-1-phosphate is decreased in patients with acute-on-chronic liver failure and predicts early mortality","volume":"4","author":"M\u00fccke","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.025_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842996","article-title":"Reduced plasma extracellular vesicle CD5L content in patients with acute-on-chronic liver failure: interplay with specialized pro-resolving lipid mediators","volume":"13","author":"S\u00e1nchez-Rodr\u00edguez","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gut.14.6.451","article-title":"Serum complement in chronic liver disease","volume":"14","author":"Potter","year":"1973","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12876-020-01258-3","article-title":"Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure","volume":"20","author":"Li","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2026.04.025_bib88","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib89","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhep.2026.04.025_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239474","article-title":"The non-canonical inflammasome activators Caspase-4 and Caspase-5 are differentially regulated during immunosuppression-associated organ damage","volume":"14","author":"Ghait","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib91","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12967-021-03135-3","article-title":"Gene profiling of Toll-like receptor signalling pathways in neutrophils of patients with acute-on-chronic liver failure","volume":"19","author":"Zhang","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100151","article-title":"Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLF","volume":"3","author":"Ortega-Ribera","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-065X.2006.00435.x","article-title":"Cellular and molecular mechanisms of liver tolerance","volume":"213","author":"Crispe","year":"2006","journal-title":"Immunological Rev"},{"key":"10.1016\/j.jhep.2026.04.025_bib94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.04.025_bib95","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fimmu.2019.00893","article-title":"The role of myeloid-derived cells in the progression of liver disease","volume":"10","author":"Weston","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib96","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.025_bib97","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib98","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jhep.2024.10.028","article-title":"Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis","volume":"82","author":"Cao","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib99","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O\u2019Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib101","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bjs.1800830804","article-title":"Peritoneal defences and peritoneum-associated lymphoid tissue","volume":"83","author":"Heel","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2026.04.025_bib102","doi-asserted-by":"crossref","unstructured":"Irvine KM, Banh X, Gadd VL, et al. CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites. JCI Insight; 1. Epub ahead of print 2 June 2016. DOI: 10.1172\/jci.insight.86914.","DOI":"10.1172\/jci.insight.86914"},{"key":"10.1016\/j.jhep.2026.04.025_bib103","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/j.gastro.2020.01.029","article-title":"Peritoneal level of CD206 associates with mortality and an inflammatory macrophage phenotype in patients with decompensated cirrhosis and spontaneous bacterial peritonitis","volume":"158","author":"Stengel","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib104","article-title":"CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis","volume":"6","author":"Niehaus","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41419-020-03060-1","article-title":"Metabolic defects in splenic B cell compartments from patients with liver cirrhosis","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s12276-024-01371-3","article-title":"CD300E+ macrophages facilitate liver regeneration after splenectomy in decompensated cirrhotic patients","volume":"57","author":"Yang","year":"2025","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmgh.2023.03.007","article-title":"AXL expression on homeostatic resident liver macrophages is reduced in cirrhosis following GAS6 production by hepatic stellate cells","volume":"16","author":"Pop","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib108","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/mi.2014.129","article-title":"The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung","volume":"8","author":"Fujimori","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib109","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.025_bib110","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20120493","article-title":"Identification of Axl as a downstream effector of TGF-\u03b21 during Langerhans cell differentiation and epidermal homeostasis","volume":"209","author":"Bauer","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)00013-1","article-title":"Bacterial translocation of enteric organisms in patients with cirrhosis","volume":"34","author":"Cirera","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib112","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib113","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1053\/j.gastro.2024.08.046","article-title":"Immune dysfunction and infection risk in advanced liver disease","volume":"168","author":"McGettigan","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib114","doi-asserted-by":"crossref","unstructured":"Qiang R, Liu X-Z, Xu J-C. The immune pathogenesis of acute-on-chronic liver failure and the danger hypothesis. Front Immunol; 13. Epub ahead of print 14 July 2022. DOI: 10.3389\/fimmu.2022.935160.","DOI":"10.3389\/fimmu.2022.935160"},{"key":"10.1016\/j.jhep.2026.04.025_bib115","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jgh.12932","article-title":"Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality","volume":"30","author":"Chen","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib116","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jhep.2024.09.046","article-title":"Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance","volume":"82","author":"Lee","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib117","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib118","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2026.04.025_bib119","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib120","doi-asserted-by":"crossref","unstructured":"Smets L., Viola M.F., Boesch M., et al. Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis. Gut Published Online First: 18 November 2025. https:\/\/doi.org\/10.1136\/gutjnl-2025-335745","DOI":"10.1136\/gutjnl-2025-335745"},{"key":"10.1016\/j.jhep.2026.04.025_bib121","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/eji.201444477","article-title":"Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: it takes three to tango","volume":"44","author":"Hoyer","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib122","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1188454","article-title":"Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses","volume":"328","author":"Hapfelmeier","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2026.04.025_bib123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004836-200603000-00015","article-title":"Colonic health: fermentation and short chain fatty acids","volume":"40","author":"Wong","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2026.04.025_bib124","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.025_bib125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/jgh.12070","article-title":"Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis","volume":"28","author":"Vlachogiannakos","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib126","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1872-034X.2012.01015.x","article-title":"Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy","volume":"42","author":"Holte","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2026.04.025_bib127","first-page":"CD008716","article-title":"Probiotics for people with hepatic encephalopathy","volume":"2","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2026.04.025_bib128","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41423-025-01313-7","article-title":"Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells","volume":"22","author":"Kostallari","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib129","doi-asserted-by":"crossref","unstructured":"Triantafyllou E, Woollard KJ, McPhail MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front Immunol; 9.","DOI":"10.3389\/fimmu.2018.02948"},{"key":"10.1016\/j.jhep.2026.04.025_bib130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2008.05.017","article-title":"Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure","volume":"49","author":"Zhang","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1083780","article-title":"Hepatocytes: a key role in liver inflammation","volume":"13","author":"Gong","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib132","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","article-title":"Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis","volume":"73","author":"Babuta","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167700","article-title":"Neutrophil extracellular traps-induced pyroptosis of liver sinusoidal endothelial cells exacerbates intrahepatic coagulation in cholestatic mice","volume":"1871","author":"Yu","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41419-020-03378-w","article-title":"M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis","volume":"12","author":"Bai","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib136","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41419-022-05181-1","article-title":"Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling","volume":"13","author":"Bai","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib137","doi-asserted-by":"crossref","unstructured":"Zhao W, Lei M, Li J, et al. Yes-associated protein inhibition ameliorates liver fibrosis and acute and chronic liver failure by decreasing ferroptosis and necroptosis. Heliyon;e15075 9. Epub ahead of print 1 April 2023. DOI: 10.1016\/j.heliyon.2023.e15075.","DOI":"10.1016\/j.heliyon.2023.e15075"},{"key":"10.1016\/j.jhep.2026.04.025_bib138","doi-asserted-by":"crossref","unstructured":"van der Heide D, Weiskirchen R, Bansal R. Therapeutic targeting of hepatic macrophages for the treatment of liver diseases. Front Immunol; 10. Epub ahead of print 3 December 2019. DOI: 10.3389\/fimmu.2019.02852.","DOI":"10.3389\/fimmu.2019.02852"},{"key":"10.1016\/j.jhep.2026.04.025_bib139","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hep4.1303","article-title":"IL-22 and IL-22-binding protein are associated with development of and mortality from acute-on-chronic liver failure","volume":"3","author":"Schwarzkopf","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.025_bib140","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib141","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2022.07.006","article-title":"Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF","volume":"77","author":"Engelmann","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15619","article-title":"Novel treatment of acute and acute-on-chronic liver failure: interleukin-22","volume":"45","author":"Hwang","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1347395","article-title":"G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF","volume":"12","author":"Ortega-Ribera","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhep.2026.04.025_bib144","unstructured":"Yaqrit Ltd. Phase II, Double-blind, Randomized, Placebo-controlled, Multicentre Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of TAK-242 and (G-CSF) in Subjects With (sAH) and (ACLF). Clin Trial Registration NCT06890039 clinicaltrials gov, https:\/\/clinicaltrials.gov\/study\/NCT06890039 (23 July 2025, accessed 6 December 2025)."},{"key":"10.1016\/j.jhep.2026.04.025_bib145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","article-title":"Hepatic encephalopathy","volume":"8","author":"H\u00e4ussinger","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2026.04.025_bib146","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1038\/s41598-024-56401-x","article-title":"Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients","volume":"14","author":"Thanapirom","year":"2024","journal-title":"Sci Rep"},{"issue":"Suppl 3","key":"10.1016\/j.jhep.2026.04.025_bib147","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1478-3231.23.s.3.1.x","article-title":"Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices","volume":"23","author":"Butterworth","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib148","article-title":"The neurogliovascular unit in hepatic encephalopathy","volume":"3","author":"Claeys","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib149","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/hep.30827","article-title":"Neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.025_bib150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40168-024-01924-8","article-title":"Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis","volume":"12","author":"Kang","year":"2024","journal-title":"Microbiome"},{"key":"10.1016\/j.jhep.2026.04.025_bib151","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jceh.2014.07.006","article-title":"Neuroinflammation in hepatic encephalopathy: mechanistic aspects","volume":"5","author":"Jayakumar","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib152","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.24326","article-title":"Microglia activation in hepatic encephalopathy in rats and humans","volume":"54","author":"Zemtsova","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.025_bib153","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jhep.2026.04.025_bib154","article-title":"Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer\u2019s disease","volume":"9","author":"Fakorede","year":"2025","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib155","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11011-014-9553-0","article-title":"The brain in acute on chronic liver failure","volume":"29","author":"Wright","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2026.04.025_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.903455","article-title":"Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation?","volume":"14","author":"Sun","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jhep.2026.04.025_bib157","doi-asserted-by":"crossref","DOI":"10.1111\/nep.70034","article-title":"The kidney and extracorporeal therapies in acute-on-chronic liver failure: what the nephrologist needs to know","volume":"30","author":"Bangera","year":"2025","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jhep.2026.04.025_bib158","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2026.04.025_bib159","first-page":"92","article-title":"Bile cast nephropathy in patients with acute kidney injury due to hepatorenal syndrome: a postmortem kidney biopsy study","volume":"5","author":"Nayak","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3350\/cmh.2024.1060","article-title":"Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum","volume":"31","author":"Girish","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib161","first-page":"190","article-title":"Acute-on-chronic liver failure: the heart and systemic hemodynamics","volume":"17","author":"Liu","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jhep.2026.04.025_bib162","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI72269","article-title":"Therapeutic translation in acute kidney injury: the epithelial\/endothelial axis","volume":"124","author":"Molitoris","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.04.025_bib163","article-title":"The pathogenesis of ischemia-reperfusion induced acute kidney injury depends on renal neutrophil recruitment whereas sepsis-induced AKI does not","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib164","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2026.04.025_bib165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib166","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1038\/s41598-018-26226-6","article-title":"Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis","volume":"8","author":"Lei","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib167","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib168","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/LVT.0000000000000231","article-title":"Plasma exchange for acute and acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"30","author":"Beran","year":"2024","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2026.04.025_bib169","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70018","article-title":"Therapeutic plasma exchange in patients with acute-on-chronic liver failure improves survival-an updated meta-analysis","volume":"45","author":"Kumar","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.04.025_bib170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2023.03.013","article-title":"Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure","volume":"79","author":"Agarwal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61658-3","article-title":"Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure","volume":"14","author":"Haselwanter","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.025_bib172","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12882-025-04342-6","article-title":"Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF)","volume":"26","author":"Sch\u00f6nfelder","year":"2025","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jhep.2026.04.025_bib173","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/aor.14774","article-title":"Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP): a single center, open-label, three-arm, randomized, controlled intervention pilot trial","volume":"48","author":"Sekandarzad","year":"2024","journal-title":"Artif Organs"},{"key":"10.1016\/j.jhep.2026.04.025_bib174","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cgh.2017.08.027","article-title":"Albumin counteracts immune-suppressive effects of lipid mediators in patients with advanced liver disease","volume":"16","author":"China","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib175","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.04.025_bib176","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.29763","article-title":"Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial","volume":"68","author":"Verma","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.025_bib177","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib178","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib179","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/hep4.1925","article-title":"Granulocyte colony-stimulating factor attenuates liver damage by M2 macrophage polarization and hepatocyte proliferation in alcoholic hepatitis in mice","volume":"6","author":"Cho","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.04.025_bib180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib181","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0168-8278(23)00561-5","article-title":"Investigating the PD-1\/PD-L pathway and macrophage responses in acute-on-chronic liver failure","volume":"78","author":"Patseas","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.025_bib182","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jhep.2025.07.034","article-title":"Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acute decompensation of cirrhosis","volume":"84","author":"Verma","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib183","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/gutjnl-2016-313443","article-title":"NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7\/8 activation","volume":"67","author":"Rolas","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib184","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2026.04.025_bib185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/HEP.0000000000000907","article-title":"Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure","volume":"81","author":"Feio-Azevedo","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.025_bib186","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2025.08.038","article-title":"Reversal of ACLF and ALF using whole blood extracorporeal system combining HLA-depleted liver organoids with granulocyte-monocyte apheresis","volume":"84","author":"Yamaguchi","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib187","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.025_bib188","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/gutjnl-2024-333876","article-title":"Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis","volume":"74","author":"Trebicka","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.025_bib189","doi-asserted-by":"crossref","unstructured":"Rice J, Dodge JL, Bambha KM, et al. Neutrophil-to-Lymphocyte ratio associates independently with mortality in hospitalized patients with cirrhosis. Clin Gastroenterol Hepatol; 0. Epub ahead of print 26 April 2018. DOI: 10.1016\/j.cgh.2018.04.045.","DOI":"10.1016\/j.cgh.2018.04.045"},{"key":"10.1016\/j.jhep.2026.04.025_bib190","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/apt.15932","article-title":"Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"52","author":"Bernsmeier","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.04.025_bib191","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.31644","article-title":"Programmed death ligand 1 is overexpressed in liver macrophages in chronic liver diseases, and its blockade improves the antibacterial activity against infections","volume":"74","author":"Pose","year":"2021","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:39:14Z","timestamp":1787380754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":191,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0168827826002291"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering immune dysfunction in ACLF: Cellular mechanisms, molecular pathways, and therapeutic frontiers","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}